Track Global Health Limited — Monitor price, dividends, and performance in your free portfolio

Start Tracking Free

Global Health Limited MEDANTA.NS · Stock Open Global Health Limited in new tab

1435.10 INR
P/E
67.73
EPS
20.69
Yield
0.03%
Safety Score
17
P/B
9.50
ROE
15.03
Beta
0.16
Target Price
1439.06 INR
Loading chart...
Key Metrics
Earnings dateAug. 6, 2026
P/E67.73
EPS20.69
Book Value147.47
Price to Book9.50
Debt/Equity29.87
% Insiders67.130%
Growth
Revenue Growth0.25%
Earnings Growth0.42%
Estimates
Forward P/E43.43
Forward EPS32.27
Target Mean Price1439.06
Dividend
Dividend Yield0.03%
Annual dividends0.50 INR
Ex-Div. DateAug. 14, 2026
Payout2.42%

DCF Valuation

Tweak assumptions to recompute fair value for Global Health Limited (MEDANTA.NS)
Currency: INR
DCF Assumptions
Decimal (e.g., 0.10 = 10%). Range allows declines (−50%) to strong growth (+50%).
Decimal (e.g., 0.30 = 30%).
Decimal (e.g., 0.04 = 4%).
Decimal (e.g., 0.20 = 20%).
Percent number (e.g., 3 = 3%).
Percent number (e.g., 10 = 10%).
Percent number (e.g., 5 = 5%).
DCF Result

Fair Value (DCF)
Current Price
Upside
WACC
Terminal PV
Σ PV of FCFs
Note: historical bars show reported FCF (for context); forward bars show PV of projected FCF; if no per-year data, totals are shown.

Global Health Limited Logo Global Health Limited Analysis (MEDANTA.NS)

Is Global Health Limited a good investment? Global Health Limited (MEDANTA.NS) is currently trading at 1435.10 INR. Market analysts have a consensus price target of 1439.06 INR. This suggests a potential upside from current levels.

In terms of valuation, the stock trades at a P/E ratio of 67.73. This high multiple suggests investors have priced in significant future growth expectations.

Earnings Schedule: Global Health Limited is expected to release its next earnings report on Aug. 6, 2026. The market consensus estimate for Forward EPS is 32.27.

For income investors, Global Health Limited pays a dividend yield of 0.03%. With a payout ratio of 2%, the dividend appears sustainable.

Investor FAQ

Does Global Health Limited pay a dividend?

Yes, it pays an annual dividend of 0.50 INR (0.03% yield).

What asset class is Global Health Limited?

Global Health Limited is classified as a Stock.

When is the next earnings date?

The next earnings date is projected to be Aug. 6, 2026. The company currently has a trailing EPS of 20.69.

Company Profile

Global Health Limited, together with its subsidiaries, provides healthcare services in India. The company offers treatments in the areas of digestive and hepatobiliary sciences, cardiac and cancer care, neurosciences, gastrosciences, orthopaedics, renal care, liver transplant, lung transplant, bone marrow transplant, chest surgery, gynaecology and gynaeoncology, paediatric care, obstetrics, emergency, ENT, head and neck surgery, internal medicine, respiratory and sleep medicine, peripheral vascular and endovascular sciences, endocrinology and diabetes, rheumatology and immunology, radiology and imaging, ophthalmology, critical care, dermatology, dentistry, and dietetics and nutrition, as well as plastic, aesthetic, and reconstructive surgery. It also provides second opinion, lab tests and diagnostics, homecare and elder care services, telemedicine and air ambulance services, and e-ICU services, and health plans checkup. In addition, the company is involved in trading of pharmacy and other medical consumables; and medical and healthcare education activities. The company operates a network of hospitals under the Medanta brand. Global Health Limited was incorporated in 2004 and is based in Gurugram, India.

Trades
Dividend Yield
0.03%
Annual Dividends
0.50INR
Next Ex. Div Date
Aug. 14, 2026
Payout Ratio
2.42%
Dividend History paid per year (INR)
Historical Dividends
Year Total Dividends
2026
1.00 INR
Oct. 19, 2026 (estimated) 0.5000
Aug. 14, 2026 0.5000
2025
0.50 INR
Oct. 19, 2025 0.5000
Upcoming Dividends
Name Payment Date Status Amount
Global Health Limited Aug 14, 2026 Upcoming 0.5 INR
Global Health Limited Oct 19, 2025 0.5 INR
Explore Premium Features

Unlock detailed news and exclusive insights with our Premium subscription.

See Pricing Plans

Fundamentals

Under Construction

This feature will be available soon. Stay tuned!

Follow us on Twitter for updates: @allinvestview

Check out our Roadmap for upcoming features.

Community Discussion